A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment

Trial Profile

A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Pitolisant (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Acronyms PoC Alcohol
  • Sponsors Bioprojet
  • Most Recent Events

    • 11 Jan 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 18 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top